HALO BioSynthesis Laboratories
2014
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer and distributor of Cannabidiol (CBD) products for clinical and natural health markets. The company specializes in CBD products and serves clients in the biotech, natural health and wellness industries, as well as the medical and retail marijuana e-liquid and edibles markets.
Website
Formerly Known As
Legacy Bio-Naturals
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- 6100 219th Street Southwest
- Suite 480
- Mountlake Terrace, WA 98043
- United States
+1 (360) 000-0000
HALO BioSynthesis Laboratories Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore HALO BioSynthesis Laboratories‘s full profile, request access.
Request full access to PitchBookHALO BioSynthesis Laboratories Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Susanne Posel | Co-Founder |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »